Morgan Nicole Y, Kramer-Marek Gabriela, Smith Paul D, Camphausen Kevin, Capala Jacek
Laboratory of Bioengineering and Physical Science, NIBIB, National Institutes of Health, Bethesda, Maryland 20892, USA.
Radiat Res. 2009 Feb;171(2):236-44. doi: 10.1667/RR1470.1.
The recent demonstration of nanoscale scintillators has led to interest in the combination of radiation and photodynamic therapy. In this model, scintillating nanoparticles conjugated to photosensitizers and molecular targeting agents would enhance the targeting and improve the efficacy of radiotherapy and extend the application of photodynamic therapy to deeply seated tumors. In this study, we calculated the physical parameters required for these nanoparticle conjugates to deliver cytotoxic levels of singlet oxygen at therapeutic radiation doses, drawing on the published literature from several disparate fields. Although uncertainties remain, it appears that the light yield of the nanoscintillators, the efficiency of energy transfer to the photosensitizers, and the cellular uptake of the nanoparticles all need to be fairly well optimized to observe a cytotoxic effect. Even so, the efficacy of the combination therapy will likely be restricted to X-ray energies below 300 keV, which limits the application to brachytherapy.
最近纳米级闪烁体的展示引发了人们对放射治疗与光动力治疗相结合的兴趣。在该模型中,与光敏剂和分子靶向剂共轭的闪烁纳米颗粒将增强靶向性,提高放射治疗的疗效,并将光动力治疗的应用扩展到深部肿瘤。在本研究中,我们借鉴了几个不同领域的已发表文献,计算了这些纳米颗粒缀合物在治疗性辐射剂量下递送细胞毒性水平单线态氧所需的物理参数。尽管仍存在不确定性,但似乎纳米闪烁体的光产额、能量转移到光敏剂的效率以及纳米颗粒的细胞摄取都需要得到相当好的优化,才能观察到细胞毒性作用。即便如此,联合治疗的疗效可能会限于300 keV以下的X射线能量,这限制了其在近距离放射治疗中的应用。